ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,787, issued on June 9, was assigned to PRESIDENT AND FELLOWS OF HARVARD COLLEGE.

"Methods and compositions relating to anti-MFSD2A antibodies" was invented by Chenghua Gu (Cambridge, Mass.), Benjamin Andreone (Cambridge, Mass.) and Urs Langen (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The technology described herein is directed to compositions comprising antibodies and antibody reagent that binds specifically to Mfsd2A and method of using such compositions, e.g., to increase blood-brain barrier permeability in therapeutic methods."

The patent was filed on Jan. 14, 2022, under Application No. 18/269,018.

*For further informatio...